These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1510000)

  • 21. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
    Przybylski R; Eberly LM; Alexander ME; Bezzerides VJ; DeWitt ES; Dionne A; Mah DY; Triedman JK; Walsh EP; O'Leary ET
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2545-2551. PubMed ID: 37846208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects.
    Sihm I; Hansen FA; Rasmussen J; Pedersen AK; Thygesen K
    Eur Heart J; 1990 Feb; 11(2):145-8. PubMed ID: 2107078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
    Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
    Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Lambardi F; Trivi M
    Cardiol J; 2014; 21(3):304-8. PubMed ID: 23990184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous propafenone for suppression of symptomatic atrial fibrillation and atrial flutter in a first aid hospital.
    Liguori A; di Ieso N; D'Armiento FP; Furia L; Napoli C; Bruzzese G; Piatto A; Varriale A
    Riv Eur Sci Med Farmacol; 1992; 14(4):229-32. PubMed ID: 1305996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation].
    Kosmala W; Kucharski W; Haczyński J; Kobusiak-Prokopowicz M
    Wiad Lek; 1994; 47(21-24):801-7. PubMed ID: 8999690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension.
    Capucci A; Lenzi T; Boriani G; Trisolino G; Binetti N; Cavazza M; Fontana G; Magnani B
    Am J Cardiol; 1992 Jul; 70(1):69-72. PubMed ID: 1615873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N; Lafuente-Lafuente C; Mitchell S; Eckert L; Reynolds M
    Europace; 2011 Mar; 13(3):329-45. PubMed ID: 21227948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
    O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course of recent-onset atrial fibrillation treated with oral propafenone.
    Weiner P; Ganam R; Ganem R; Zidan F; Rabner M
    Chest; 1994 Apr; 105(4):1013-6. PubMed ID: 8162718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of flecainide for the reversion of acute onset atrial fibrillation.
    Donovan KD; Dobb GJ; Coombs LJ; Lee KY; Weekes JN; Murdock CJ; Clarke GM
    Am J Cardiol; 1992 Aug; 70(5):50A-54A; discussion 54A-55A. PubMed ID: 1509999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1:1 atrial flutter induced by flecainide, whilst the patient was at rest.
    Comelli I; Pigna F; Cervellin G
    Am J Emerg Med; 2018 Nov; 36(11):2131.e3-2131.e5. PubMed ID: 30033133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of propafenone in emergency therapy].
    Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
    Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
    Naccarelli GV; Dell'Orfano JT; Wolbrette DL; Patel HM; Luck JC
    Am J Cardiol; 2000 May; 85(10A):36D-45D. PubMed ID: 10822039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.